Shosaku Nomura
Shosaku Nomura
Immune thrombocytopenia (ITP) is an acquired hemorrhagic condition characterized by the accelerated clearance of platelets caused by antiplatelet autoantibodies. A platelet count in peripheral blood
Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival [0.03%]
尼日利亚慢性髓性白血病患者的贫血是总生存率的独立预测因素
Anthony A Oyekunle,Muheez A Durosinmi,Ramoni A Bolarinwa et al.
Anthony A Oyekunle et al.
Objectives: The advent of the tyrosine kinase inhibitors has markedly changed the prognostic outlook for patients with Ph(+) and/or BCR-ABL1 (+) chronic myeloid leukemia (CML). This study was designed to assess the overal...
Pediatric Blood Pressure and Adult Preclinical Markers of Cardiovascular Disease [0.03%]
儿童血压与成人心血管疾病前兆指标的关系
Costan G Magnussen,Kylie J Smith
Costan G Magnussen
A high blood pressure level in adults is considered the single most important modifiable risk factor for global disease burden, especially those of cardiovascular (CV) origin such as stroke and ischemic heart disease. Because blood pressure...
Mixed Phenotype Acute Leukemia with Two Immunophenotypically Distinct B and T Blasts Populations, Double Ph (+) Chromosome and Complex Karyotype: Report of an Unusual Case [0.03%]
两种不同免疫表型的B和T原始细胞群、双Ph（+）染色体和复杂核型的混合表型急性白血病一例报告
Samah A Kohla,Ahmad Al Sabbagh,Halima El Omri et al.
Samah A Kohla et al.
Mixed phenotype acute leukemia (MPAL) is considered as a rare type of leukemia with an incidence of less than 4% of all acute leukemia based on the most recent 2008 WHO classification. Common subtypes are the B/myeloid and T/myeloid; B/T an...
Dasatinib Induced Avascular Necrosis of Femoral Head in Adult Patient with Chronic Myeloid Leukemia [0.03%]
达沙替尼导致慢性髓性白血病成人患者股骨头无血管坏死
Mohamed A Yassin,Abbas H Moustafa,Abdulqadir J Nashwan et al.
Mohamed A Yassin et al.
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the presence of the Philadelphia (Ph) chromosome resulting from the reciprocal translocation t(9;22)(q34;q11). The molecular consequence of this translocation ...
Anemia and the Need for Intravenous Iron Infusion after Roux-en-Y Gastric Bypass [0.03%]
胃旁路术后贫血和静脉输注铁剂的需求
Adam Kotkiewicz,Keri Donaldson,Charles Dye et al.
Adam Kotkiewicz et al.
The frequency of anemia, iron deficiency, and the long-term need for IV iron following Roux-en-y gastric bypass (RYGB) surgery has not been well characterized. Three-hundred and nineteen out of 904 consecutive subjects who underwent RYGB at...
Efficacy and Safety of Rituximab for Refractory and Relapsing Thrombotic Thrombocytopenic Purpura: A Cohort of 10 Cases [0.03%]
利妥昔单抗治疗难治性复发性血栓性血小板减少性紫癜的疗效和安全性：10例队列研究
Halima El Omri,Ruba Y Taha,Amna Gamil et al.
Halima El Omri et al.
Objective: Idiopathic thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder mediated by autoantibodies directed against ADAMTS13. This provides a rationale for the use of rituximab in this disorder. We ...
Hani Nakhoul,Jiangwei Ke,Xiang Zhou et al.
Hani Nakhoul et al.
Ribosomopathies are diseases caused by alterations in the structure or function of ribosomal components. Progress in our understanding of the role of the ribosome in translational and transcriptional regulation has clarified the mechanisms ...
Awa Ot Fall,Valérie Proulle,Abibatou Sall et al.
Awa Ot Fall et al.
Little is known about the biological, epidemiological, and clinical risk factors for thrombosis and venous thromboembolism (VTE) among Black Africans. We undertook a study of the prevalence of VTE risk factors for thrombosis in a Senegalese...
Clinical Characteristics and Risk of Relapse for Patients with Stage I-II Diffuse Large B-cell Lymphoma Treated in First Line with Immunochemotherapy [0.03%]
一线即刻免疫化疗后早期发病的弥漫大B细胞淋巴瘤患者的临床特点及复发风险
S Mercadal,F Climent,E Domingo-Doménech et al.
S Mercadal et al.
Diffuse large b-cell lymphoma (DLBCL) is an aggressive and potentially curable lymphoma that presents itself as stage I-II in 30% of all cases. It is known that in these localized stages, 15-20% of patients treated without rituximab eventua...